2002
DOI: 10.1002/jso.10110
|View full text |Cite
|
Sign up to set email alerts
|

Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five‐year results of a phase I–II study and initial findings of a randomized phase III trial

Abstract: Five-year results of our phase I-II study prove that sole HDR-BT of the tumor bed with careful patient selection and adequate quality assurance is a feasible alternative to WBRT. However, long-term results of phase III trials are required to determine the equivalence of TBRT alone, compared with WBRT in the management of selected patients with early breast cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
85
0
5

Year Published

2003
2003
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 225 publications
(93 citation statements)
references
References 29 publications
3
85
0
5
Order By: Relevance
“…Even when comparing relatively similar brachy-therapy techniques for delivering APBI, there remains uncertainty regarding the appropriate dosimetric criteria needed to minimize the risk of toxicities such as fat necrosis. In the initial clinical experiences with interstitial catheter-based brachy-therapy, symptomatic fat necrosis reported range from 2% to 21% of cases [81,82] .The current guidelines in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-39/RTOG 0413 protocol regarding the volume of higher doses of radiation permissible on study are based on earlier dosimetric analyses from Tufts University and Virginia Commonwealth University that correlated larger volumes of high doses of radiation in the breast with the development of fat necrosis [83]. It is difficult to know how to translate these dosimetric constraints from one brachytherapy modality to another, which is important given that balloon and single-entry catheter based brachytherapy catheters yield significantly different dose distributions.…”
Section: Comparison Of Apbi Modalities:-mentioning
confidence: 99%
“…Even when comparing relatively similar brachy-therapy techniques for delivering APBI, there remains uncertainty regarding the appropriate dosimetric criteria needed to minimize the risk of toxicities such as fat necrosis. In the initial clinical experiences with interstitial catheter-based brachy-therapy, symptomatic fat necrosis reported range from 2% to 21% of cases [81,82] .The current guidelines in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-39/RTOG 0413 protocol regarding the volume of higher doses of radiation permissible on study are based on earlier dosimetric analyses from Tufts University and Virginia Commonwealth University that correlated larger volumes of high doses of radiation in the breast with the development of fat necrosis [83]. It is difficult to know how to translate these dosimetric constraints from one brachytherapy modality to another, which is important given that balloon and single-entry catheter based brachytherapy catheters yield significantly different dose distributions.…”
Section: Comparison Of Apbi Modalities:-mentioning
confidence: 99%
“…Interstitial implants have been in use for over 10 years and published reports describe excellent results; however, these are mainly single-institution Phase I/II studies [39][40][41][42][43][44][45][46]. The largest matched-pair analysis from the William Beaumont Hospital compared 199 interstitial catheter APBI patients treated between 1980 and 1997 with 199 WBRT patients randomly selected from 709 eligible control subjects [39].…”
Section: Brachytherapymentioning
confidence: 99%
“…However, no subset of patients who should forego radiation therapy after BCS has been identified [11][12][13] and local recurrence after BCS with WBI is most likely to occur in the vicinity of the lumpectomy site [14][15][16][17]. Considering the above, the efficacy and feasibility of accelerated partial breast irradiation (APBI) as an alternative to WBI have been evaluated in many Phases II and III studies [18][19][20][21][22].…”
Section: Introductionmentioning
confidence: 99%